XOMA Corp

NASDAQ XOMAP

Data sourced from iex and EODHD
Download Data

XOMA Corp Pre-Tax Margin for the Trailing 12 Months (TTM) ending March 31, 2024: -470.07%

XOMA Corp Pre-Tax Margin is -470.07% for the Trailing 12 Months (TTM) ending March 31, 2024, a 65.75% change year over year. Pre-tax margin represents the proportion of a company's earnings before taxes (EBT) to its revenue. It is calculated by dividing the EBT by the revenue. This ratio indicates the profitability of the company's operations before the impact of taxes. A higher pre-tax margin suggests that the company generates a larger proportion of revenue as pre-tax profit, indicating stronger operational performance and efficiency.
  • XOMA Corp Pre-Tax Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -1,372.57%.
NASDAQ: XOMAP

XOMA Corp

CEO -
IPO Date Dec. 16, 2020
Location United States
Headquarters 2200 Powell Street, EmeryVille, CA, United States, 94608
Employees 13
Sector Healthcare
Industry Biotechnology
Description

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Similar companies

XOMAO

XOMA Corporation

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email